BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lahalle A, Lacroix M, De Blasio C, Cissé MY, Linares LK, Le Cam L. The p53 Pathway and Metabolism: The Tree That Hides the Forest. Cancers (Basel) 2021;13:E133. [PMID: 33406607 DOI: 10.3390/cancers13010133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun H, Li L, Li W, Yang F, Zhang Z, Liu Z, Du W. p53 transcriptionally regulates SQLE to repress cholesterol synthesis and tumor growth. EMBO Rep 2021;22:e52537. [PMID: 34459531 DOI: 10.15252/embr.202152537] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Xiang X, Zhu J, Zhang G, Ma Z, Livingston MJ, Dong Z. Proximal Tubule p53 in Cold Storage/Transplantation-Associated Kidney Injury and Renal Graft Dysfunction. Front Med (Lausanne) 2021;8:746346. [PMID: 34746182 DOI: 10.3389/fmed.2021.746346] [Reference Citation Analysis]
3 Gousias K, Theocharous T, Simon M. Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma. Biomedicines 2022;10:564. [DOI: 10.3390/biomedicines10030564] [Reference Citation Analysis]
4 Wang C, Wang C, Mai R, Chen T, Li C, Chao C. Mutant p53-microRNA-200c-ZEB2-Axis-Induced CPT1C Elevation Contributes to Metabolic Reprogramming and Tumor Progression in Basal-Like Breast Cancers. Front Oncol 2022;12:940402. [DOI: 10.3389/fonc.2022.940402] [Reference Citation Analysis]
5 Gavriatopoulou M, Paschou SA, Ntanasis-Stathopoulos I, Dimopoulos MA. Metabolic Disorders in Multiple Myeloma. Int J Mol Sci 2021;22:11430. [PMID: 34768861 DOI: 10.3390/ijms222111430] [Reference Citation Analysis]
6 Bergasa-caceres F, Rabitz HA. Interdiction in the Early Folding of the p53 DNA-Binding Domain Leads to Its Amyloid-Like Misfolding. Molecules 2022;27:4810. [DOI: 10.3390/molecules27154810] [Reference Citation Analysis]
7 Lynch KN, Liu JF, Kesten N, Chow KH, Shetty A, He R, Afreen MF, Yuan L, Matulonis UA, Growdon WB, Muto MG, Horowitz NS, Feltmate CM, Worley MJ Jr, Berkowitz RS, Crum CP, Rueda BR, Hill SJ. Enhanced Efficacy of Aurora Kinase Inhibitors in G2/M Checkpoint Deficient TP53 Mutant Uterine Carcinomas Is Linked to the Summation of LKB1-AKT-p53 Interactions. Cancers (Basel) 2021;13:2195. [PMID: 34063609 DOI: 10.3390/cancers13092195] [Reference Citation Analysis]
8 Horvat A, Tadijan A, Vlašić I, Slade N. p53/p73 Protein Network in Colorectal Cancer and Other Human Malignancies. Cancers (Basel) 2021;13:2885. [PMID: 34207603 DOI: 10.3390/cancers13122885] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Milani D, Caruso L, Zauli E, Al Owaifeer AM, Secchiero P, Zauli G, Gemmati D, Tisato V. p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics). Front Pharmacol 2022;13:871583. [DOI: 10.3389/fphar.2022.871583] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]